
FTRP
Healthcare · Health Care Providers & Services · $9.8M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2022
EPS trend, 90 days to now · +11.8% over 90 days · 30-day revisions 0 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2022 | Time not confirmed | -0.27 | -0.90 | -237.4% |
| Aug 15, 2022 | After the close | -1.00 | -0.23 | +77.0% |
| Jun 28, 2022 | After the close | -1.13 | -1.20 | -6.2% |
| Feb 14, 2022 | After the close | -1.01 | -1.30 | -28.7% |
| Nov 14, 2021 | After the close | -0.92 | -1.15 | -25.0% |
| Aug 16, 2021 | After the close | -0.65 | -1.10 | -69.2% |
| Jun 24, 2021 | After the close | -0.65 | -0.90 | -38.5% |
| Feb 16, 2021 | After the close | -0.55 | -1.10 | -100.0% |
| Oct 24, 2020 | Before the open | — | -0.95 | — |
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of…